Carmel Capital Partners, LLC Bristol Myers Squibb CO Transaction History

Carmel Capital Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $977,762 - $1.09 Million	-16,890 Reduced 82.5%	3,583 $207,000
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $1,337 - $1,485	21 Added 0.1%	20,473 $1.31 Million
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $80,297 - $91,075	1,222 Added 6.35%	20,452 $1.42 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $198,181 - $234,674	-2,894 Reduced 13.08%	19,230 $0
Q3 2022 Oct 14, 2022	BUY	$0.13 - $76.84 $45 - $26,894	350 Added 1.61%	22,124 $1.57 Million
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $291,569 - $321,119	-4,015 Reduced 15.57%	21,774 $1.68 Million
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $50,413 - $60,450	820 Added 3.28%	25,789 $1.88 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $1.34 Million - $1.56 Million	24,969 New	24,969 $1.56 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Carmel Capital Partners, LLC with notifications on news.